Litcius/Paper detail

Higher-Valency Pneumococcal Conjugate Vaccines: An Exploratory Cost-Effectiveness Analysis in U.S. Seniors

Kenneth J. Smith, Angela R. Wateska, Mary Patricia Nowalk, Chyongchiou J. Lin, Lee H. Harrison, William Schaffner, Richard K. Zimmerman

2021American Journal of Preventive Medicine27 citationsDOIOpen Access PDF

Topics & Concepts

Pneumococcal conjugate vaccineHerd immunityMedicineVaccinationConjugate vaccineCost effectivenessQuality-adjusted life yearEnvironmental healthImmunologyImmunizationStreptococcus pneumoniaeImmune systemBiologyRisk analysis (engineering)BacteriaGeneticsPneumonia and Respiratory InfectionsRespiratory viral infections researchInfluenza Virus Research Studies
Higher-Valency Pneumococcal Conjugate Vaccines: An Exploratory Cost-Effectiveness Analysis in U.S. Seniors | Litcius